Skip to main content

Illinois IGB

Thomas Gaj

New CRISPR base-editing technology slows ALS progression in mice

February 24, 2020

With a new CRISPR gene-editing methodology, scientists from the University of Illinois at Urbana-Champaign inactivated one of the genes responsible for an inherited form of amyotrophic lateral sclerosis – a debilitating and fatal neurological disease for which there is no cure. The novel treatment slowed disease progression, improved muscle function and extended lifespan in mice with an aggressive form of ALS.


February 24, 2020


Related Articles

Subscribe to Thomas Gaj